Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Development of therapeutics to maintain vaccine immunity following exposure to ionizing radiation.

Hugh I McFarland, Ryan T Surujdin, Joseph Aryankalayil, Julia D. Berkson, Jay P. Lee and Amy S. Rosenberg
J Immunol May 1, 2017, 198 (1 Supplement) 79.30;
Hugh I McFarland
1CDER, FDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan T Surujdin
1CDER, FDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Aryankalayil
1CDER, FDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia D. Berkson
1CDER, FDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay P. Lee
1CDER, FDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy S. Rosenberg
1CDER, FDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 198 no. 1 Supplement 79.30

Published By 
The American Association of Immunologists, Inc.
Print ISSN 
0022-1767
Online ISSN 
1550-6606
History 
  • Published online June 13, 2017.

Copyright & Usage 
Copyright © 2017 by The American Association of Immunologists, Inc.

Author Information

  1. Hugh I McFarland1,
  2. Ryan T Surujdin1,
  3. Joseph Aryankalayil1,
  4. Julia D. Berkson1,
  5. Jay P. Lee1 and
  6. Amy S. Rosenberg1
  1. 1CDER, FDA

Article usage

Article usage: June 2017 to May 2022

AbstractFullPdf
Jun 2017100
Jul 2017500
Aug 2017900
Sep 20171400
Oct 2017700
Nov 2017200
Dec 2017500
Total 20174300
Jan 20182300
Feb 2018500
Mar 2018400
Apr 2018300
May 2018800
Jun 2018600
Jul 2018700
Oct 2018600
Nov 2018800
Dec 2018200
Total 20187200
Jan 2019300
Feb 2019400
Mar 2019500
May 2019400
Jun 2019200
Jul 2019600
Aug 2019200
Sep 2019200
Oct 2019200
Nov 2019200
Dec 2019300
Total 20193500
Jan 2020400
Feb 20204100
Mar 20202500
Apr 20201500
Jun 2020200
Jul 2020100
Aug 2020400
Sep 2020100
Oct 2020702
Nov 2020100
Dec 2020200
Total 202010302
Feb 2021300
Mar 2021300
Apr 2021200
May 2021300
Jun 2021300
Jul 2021100
Aug 2021300
Sep 2021300
Oct 2021200
Nov 2021200
Dec 2021300
Total 20212800
Jan 2022600
Feb 2022200
Mar 2022300
Apr 2022200
May 2022300
Total 20221600
Total29702

Previous
Back to top

In this issue

The Journal of Immunology
Vol. 198, Issue 1 Supplement
1 May 2017
  • Table of Contents
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development of therapeutics to maintain vaccine immunity following exposure to ionizing radiation.
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Development of therapeutics to maintain vaccine immunity following exposure to ionizing radiation.
Hugh I McFarland, Ryan T Surujdin, Joseph Aryankalayil, Julia D. Berkson, Jay P. Lee, Amy S. Rosenberg
The Journal of Immunology May 1, 2017, 198 (1 Supplement) 79.30;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development of therapeutics to maintain vaccine immunity following exposure to ionizing radiation.
Hugh I McFarland, Ryan T Surujdin, Joseph Aryankalayil, Julia D. Berkson, Jay P. Lee, Amy S. Rosenberg
The Journal of Immunology May 1, 2017, 198 (1 Supplement) 79.30;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

  • Tumor Lysate Loaded Dendritic Cells Induce a T cell Specific Antitumor Response Against Gallbladder Cancer
  • CD11c+ MHCIIint bone marrow-derived dendritic cells as adjuvants for neoepitope – based cancer immunotherapy
  • Humanized HLA-DQ8αβ transgenic mice treated with SEG/SEI superantigens exhibit long-term CD4+-mediated anti-tumor responses.
Show more Novel Strategies for Cancer Vaccines

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606